2. CS011MEN1-n4.Corrected1
CSMCi001-A-2
General
Cell Line |
|
| hPSCreg name | CSMCi001-A-2 |
| Cite as: | CSMCi001-A-2 (RRID:CVCL_D0DP) |
| Alternative name(s) |
2. CS011MEN1-n4.Corrected1
|
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Similar lines |
CSMCi001-A-1 (CS011iMEN1-n4.Homo5, CS011MEN1-n4.HomoMut5) Donor diseases: multiple endocrine neoplasia type 1 |
| Last update | 14th April 2023 |
| User feedback | |
Provider |
|
| Generator | Cedars Sinai Medical Center, (CSMC) |
External Databases |
|
| BioSamples | SAMEA112648670 |
| Cellosaurus | CVCL_D0DP |
| Wikidata | Q123030974 |
General Information |
|
| Publications | |
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
| Subclone of | |
Donor Information
General Donor Information |
|
| Sex | female |
Phenotype and Disease related information (Donor) |
|
| Diseases | A disease was diagnosed.
|
External Databases (Donor) |
|
| BioSamples | SAMEA112648427 |
Ethics
Also have a look at the ethics information for the parental line
CSMCi001-A
.
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
|
The source cell information can be found in the parental cell line
CSMCi001-A.
|
|
Reprogramming method |
|
| Vector type | None |
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
Unknown |
| Derived under GMP? |
Unknown |
| Available as clinical grade? |
Unknown |
Culture Conditions
| Medium |
mTeSR™ Plus
|
Characterisation
No characterisation data could be found for this subclone. Please open parental cell line CSMCi001-A .Genotyping
Karyotyping (Cell Line) |
|
Other Genotyping (Cell Line) |
Genetic Modification
| Disease/phenotype related modifications |
|
Login to share your feedback, experiences or results with the research community.